State Street SPDR S&P Biotech ETF XBI

SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.

ARCA:XBI - Post by User

State Street SPDR S&P Biotech ETF

<< Previous

Bullboard Posts

(96)
•••

Post by inviolablspiriton Apr 08, 2025 10:32am

72 Views

Post# 36528882

CEO Nick Kadysh - Pharmala Biotech Interview

For investors interested in the psychedelics sector of biotech. Pharmala Biotech the #1 supplier of GMP MDMA for clinical trials worldwide. The company is a supplier of MDMA for commercial purposes and for clincial trials and research and they research and develop their own novel MDMA molecules.

#AlphaNooner - Nick Kadysh PharmAla Biotech

<< Previous

Bullboard Posts

The mental health economy: Investing in the world’s fastest-growing invisible market